The cancer antibody conjugate market is rapidly expanding, highlighted by increased patent filings and clinical trials. Key opportunities include strategic positioning in antibody, linker, and payload ...
Protein‐polymer conjugates represent a dynamic class of hybrid materials that combine the inherent biological function and specificity of proteins with the versatile properties of synthetic polymers.